Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?
Authors
Keywords
Antifungal resistance, Resistance mechanisms, <em class=EmphasisTypeItalic >Candida</em> resistance, Intensive care unit, Clinical resistance, Microbial resistance
Journal
INTENSIVE CARE MEDICINE
Volume 40, Issue 9, Pages 1241-1255
Publisher
Springer Nature
Online
2014-08-04
DOI
10.1007/s00134-014-3404-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Positions and Numbers ofFKSMutations in Candida albicans Selectively InfluenceIn VitroandIn VivoSusceptibilities to Echinocandin Treatment
- (2014) M. Lackner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates
- (2014) Gregory A. Eschenauer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin
- (2014) Fernando César Bizerra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tissue Penetration of Antifungal Agents
- (2014) T. Felton et al. CLINICAL MICROBIOLOGY REVIEWS
- Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU*
- (2014) Mireia Puig-Asensio et al. CRITICAL CARE MEDICINE
- Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
- (2014) Maiken C. Arendrup et al. DRUG RESISTANCE UPDATES
- A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality
- (2014) Matteo Bassetti et al. INTENSIVE CARE MEDICINE
- Amphotericin forms an extramembranous and fungicidal sterol sponge
- (2014) Thomas M Anderson et al. Nature Chemical Biology
- Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients
- (2013) Thomas S. Y. Chan et al. ANNALS OF HEMATOLOGY
- Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?
- (2013) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of Matrix β-1,3 Glucan in Antifungal Resistance of Non-albicans Candida Biofilms
- (2013) K. F. Mitchell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure
- (2013) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin
- (2013) A. Fekkar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Paradoxical Growth of Candida albicans in the Presence of Caspofungin Is Associated with Multiple Cell Wall Rearrangements and Decreased Virulence
- (2013) Cristina Rueda et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Brazilian guidelines for the management of candidiasis – a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical
- (2013) Arnaldo Lopes Colombo et al. Brazilian Journal of Infectious Diseases
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal
- (2013) S. Leroux et al. CLINICAL MICROBIOLOGY AND INFECTION
- Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
- (2013) Richard J. Hamill DRUGS
- Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms
- (2013) Nicolas Delattin et al. Future Medicinal Chemistry
- Mechanisms ofCandidabiofilm drug resistance
- (2013) Heather T Taff et al. Future Microbiology
- Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)
- (2013) M. T. Montagna et al. INFECTION
- Candidaemia in the non-neutropenic patient: A critique of the guidelines
- (2013) A. Deshpande et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases
- (2013) Yanan Zhao et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study
- (2013) W. Liu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia across Five Sites in Italy and Spain
- (2013) M. Bassetti et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria
- (2013) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
- (2013) Benjamin Matteson Vincent et al. PLOS BIOLOGY
- The Presence of anFKSMutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata
- (2012) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
- (2012) D. R. Andes et al. CLINICAL INFECTIOUS DISEASES
- Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011
- (2012) A. A. Cleveland et al. CLINICAL INFECTIOUS DISEASES
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
- (2012) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- The changing epidemiology of healthcare-associated candidemia over three decades
- (2012) Daniel Diekema et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Amino acid substitutions in the Candida albicans sterol 5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence
- (2012) F. Morio et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata
- (2012) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Practical considerations on current guidelines for the management of non-neutropenic adult patients with candidaemia
- (2012) A. Glöckner et al. MYCOSES
- Amphotericin primarily kills yeast by simply binding ergosterol
- (2012) K. C. Gray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment
- (2011) Michael A. Pfaller AMERICAN JOURNAL OF MEDICINE
- Loss of Mitochondrial Functions Associated with Azole Resistance in Candida glabrata Results in Enhanced Virulence in Mice
- (2011) Sélène Ferrari et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin ResistanceIn Vivo
- (2011) Keunsook K. Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ECIL 3-2009 update guidelines for antifungal management
- (2011) L Castagna et al. BONE MARROW TRANSPLANTATION
- Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
- (2011) M.A. Pfaller et al. DRUG RESISTANCE UPDATES
- Effects of Fluconazole on the Secretome, the Wall Proteome, and Wall Integrity of the Clinical Fungus Candida albicans
- (2011) Alice G. Sorgo et al. EUKARYOTIC CELL
- Current perspectives on echinocandin class drugs
- (2011) David S Perlin Future Microbiology
- Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)
- (2011) Michael A. Pfaller et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antifungal use influences Candida species distribution and susceptibility in the intensive care unit
- (2011) P. Fournier et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy
- (2011) Markus Ruhnke et al. MYCOSES
- Antifungal susceptibility of Candida albicans in biofilms
- (2011) Selma Tobudic et al. MYCOSES
- Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms
- (2011) Margarida Martins et al. MYCOSES
- Hsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms
- (2011) Nicole Robbins et al. PLoS Pathogens
- Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
- (2010) Olivier Lortholary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species
- (2010) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients*
- (2010) Yves Cohen et al. CRITICAL CARE MEDICINE
- Epidemiology of Invasive Mycoses in North America
- (2010) Michael A. Pfaller et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature
- (2010) Florent Morio et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods
- (2010) M.A. Pfaller et al. DRUG RESISTANCE UPDATES
- Breakthrough Invasive Candidiasis in Patients on Micafungin
- (2010) C. D. Pfeiffer et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Rapid Antifungal Susceptibility Determination for Yeast Isolates by Use of Etest Performed Directly on Blood Samples from Patients with Fungemia
- (2010) J. Guinea et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Comparison of the Vitek 2 Antifungal Susceptibility System with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest Techniques for In Vitro Detection of Antifungal Resistance in Yeast Isolates
- (2010) M. Cuenca-Estrella et al. JOURNAL OF CLINICAL MICROBIOLOGY
- PKC Signaling Regulates Drug Resistance of the Fungal Pathogen Candida albicans via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90
- (2010) Shantelle L. LaFayette et al. PLoS Pathogens
- Acquisition of Flucytosine, Azole, and Caspofungin Resistance in Candida glabrata Bloodstream Isolates Serially Obtained from a Hematopoietic Stem Cell Transplant Recipient
- (2009) F. Chapeland-Leclerc et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nonsense and Missense Mutations in FCY2 and FCY1 Genes Are Responsible for Flucytosine Resistance and Flucytosine-Fluconazole Cross-Resistance in Clinical Isolates of Candida lusitaniae
- (2009) M. Florent et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing
- (2009) Huiping Wang et al. BMC MICROBIOLOGY
- Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter‐Related Infection: 2009 Update by the Infectious Diseases Society of America
- (2009) Leonard A. Mermel et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Liposomal Amphotericin B
- (2009) Marit D. Moen et al. DRUGS
- Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation
- (2009) Dominique Sanglard et al. FEMS YEAST RESEARCH
- Fungal echinocandin resistance
- (2009) Louise A. Walker et al. FUNGAL GENETICS AND BIOLOGY
- Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review
- (2009) Hsin-Yun Sun et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Formation of new chromosomes as a virulence mechanism in yeastCandida glabrata
- (2009) Silvia Poláková et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Caspofungin-Resistant Candida tropicalis Strains Causing Breakthrough Fungemia in Patients at High Risk for Hematologic Malignancies
- (2008) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pyrosequencing To Detect Mutations in FKS1 That Confer Reduced Echinocandin Susceptibility in Candida albicans
- (2008) N. P. Wiederhold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Breakthrough Aspergillus fumigatus and Candida albicans Double Infection during Caspofungin Treatment: Laboratory Characteristics and Implication for Susceptibility Testing
- (2008) M. C. Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility
- (2008) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
- (2008) Brahm H. Segal et al. CLINICAL INFECTIOUS DISEASES
- Factors Associated with Candidemia Caused by Non‐albicans CandidaSpecies VersusCandida albicansin the Intensive Care Unit
- (2008) Jennifer K. Chow et al. CLINICAL INFECTIOUS DISEASES
- EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts
- (2008) J.L. Rodriguez-Tudela et al. CLINICAL MICROBIOLOGY AND INFECTION
- Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy
- (2008) N. Kabbara et al. HAEMATOLOGICA
- Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment
- (2008) Benoît P. Guery et al. INTENSIVE CARE MEDICINE
- Resistance to Antifungal Agents: Mechanisms and Clinical Impact
- (2007) Z. A. Kanafani et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now